Data / Form D filings / EXUMA Biotech Corp.
EXUMA Biotech Corp.: Form D filings
EXUMA Biotech Corp., a biotechnology company in West Palm Beach, FL, filed 3 Form D notices with the SEC between 2017 and 2026. The latest, on August 20, 2026, reports $70 million sold of a $70 million offering to 26 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 625 N. FLAGLER DRIVE SUITE 625, West Palm Beach, FL, 33401
- Phone
- (858) 200-5193
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1698021
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | New notice | $70,000,000 | $70,000,000 | 26 | May 26, 2026 | sec.gov | |
| Apr 21, 2020 | New notice | $18,950,000 | $18,950,000 | 12 | Dec 19, 2019 | sec.gov | |
| Feb 23, 2017 | New notice | $93,999,996 | $44,000,007 | $49,999,989 | 3 | Jun 7, 2016 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Gregory Frost | Executive Officer, Director | Chairman and Chief Executive Officer |
| David Ramsay | Director | |
| Daniel Flynn | Director | |
| Houston Holmes | Director | |
| Frank McCormick | Director | |
| Richard Yan | Executive Officer | Principal Accounting Officer |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of Aug 17, 2026 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what EXUMA Biotech Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.